RARE
Price
$44.19
Change
-$0.76 (-1.69%)
Updated
Dec 18, 10:53 AM (EDT)
57 days until earnings call
ROIV
Price
$12.15
Change
-$0.00 (-0.00%)
Updated
Dec 18, 10:55 AM (EDT)
61 days until earnings call
Ad is loading...

RARE vs ROIV

Header iconRARE vs ROIV Comparison
Open Charts RARE vs ROIVBanner chart's image
Ultragenyx Pharmaceutical
Price$44.19
Change-$0.76 (-1.69%)
Volume$100
CapitalizationN/A
Roivant Sciences
Price$12.15
Change-$0.00 (-0.00%)
Volume$27.81K
CapitalizationN/A
RARE vs ROIV Comparison Chart
Loading...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RARE vs. ROIV commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RARE is a Hold and ROIV is a StrongBuy.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (RARE: $44.95 vs. ROIV: $12.15)
Brand notoriety: RARE and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RARE: 140% vs. ROIV: 88%
Market capitalization -- RARE: $4.15B vs. ROIV: $8.84B
RARE [@Biotechnology] is valued at $4.15B. ROIV’s [@Biotechnology] market capitalization is $8.84B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RARE’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 1 green FA rating(s).

  • RARE’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 1 green, 4 red.
According to our system of comparison, ROIV is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RARE’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 6 bullish TA indicator(s).

  • RARE’s TA Score: 4 bullish, 4 bearish.
  • ROIV’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than RARE.

Price Growth

RARE (@Biotechnology) experienced а -8.43% price change this week, while ROIV (@Biotechnology) price change was +0.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.45%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

RARE is expected to report earnings on Feb 13, 2025.

ROIV is expected to report earnings on Feb 17, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($8.85B) has a higher market cap than RARE($4.15B). ROIV YTD gains are higher at: 8.192 vs. RARE (-6.002). ROIV has higher annual earnings (EBITDA): 4.15B vs. RARE (-461.54M). ROIV has more cash in the bank: 5.39B vs. RARE (622M). RARE has less debt than ROIV: RARE (34.1M) vs ROIV (52.7M). RARE has higher revenues than ROIV: RARE (523M) vs ROIV (129M).
RAREROIVRARE / ROIV
Capitalization4.15B8.85B47%
EBITDA-461.54M4.15B-11%
Gain YTD-6.0028.192-73%
P/E RatioN/A2.19-
Revenue523M129M405%
Total Cash622M5.39B12%
Total Debt34.1M52.7M65%
FUNDAMENTALS RATINGS
RARE: Fundamental Ratings
RARE
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RAREROIV
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 6 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
64%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 3 days ago
70%
View a ticker or compare two or three
Ad is loading...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GSEE46.02N/A
N/A
Goldman Sachs MarketBeta Emer Mkt Eq ETF
CADHKD5.46N/A
N/A
Canadian Dollar - Hong Kong Dollar
AOM44.55-0.08
-0.18%
iShares Core Moderate Allocation ETF
CVAR26.81-0.10
-0.36%
Cultivar ETF
EEMS59.19-0.27
-0.46%
iShares MSCI Emerging Markets Sm-Cp ETF

RARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, RARE has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RARE jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RARE
1D Price
Change %
RARE100%
-0.99%
VCYT - RARE
46%
Loosely correlated
-2.52%
CRNX - RARE
44%
Loosely correlated
+1.35%
ROIV - RARE
43%
Loosely correlated
+0.41%
DNLI - RARE
42%
Loosely correlated
-0.30%
PGEN - RARE
41%
Loosely correlated
+2.46%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+0.41%
IMVT - ROIV
57%
Loosely correlated
+1.01%
ARGX - ROIV
46%
Loosely correlated
+0.90%
AXON - ROIV
43%
Loosely correlated
-2.09%
RARE - ROIV
41%
Loosely correlated
-0.99%
PGEN - ROIV
41%
Loosely correlated
+2.46%
More